Oragenics Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for OGEN, updated each market day.
OGEN AI Sentiment
AI predicts Oragenics Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Oragenics Inc.
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
Sector
Exchange
Market Cap
$2,341,705
Cap Tier
Employees
3
Headquarters
LAKEWOOD RANCH, FL
Listed Since
July 3, 2003
Website
OGEN Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
OGEN Volatility
Oragenics Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
